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Abstract The ABCA3 gene, of the ABCA subclass of ATP-
binding cassette (ABC) transporters, is expressed exclusively in
lung. We report here the cloning, molecular characterization, and
distribution of human ABCA3 in the lung. Immunoblot analysis
using the specific antibody reveals a 150-kDa protein in the crude
membrane fraction of human lung. Immunohistochemical anal-
yses of alveoli show that ABCA3 is expressed only in the type II
cells expressing surfactant protein A. At the ultrastructural level,
ABCA3 immunoreactivity was detected mostly at the limiting
membrane of the lamellar bodies. Since members of the ABCA
transporter family are known to be involved in transmembrane
transport of endogenous lipids, our findings suggest that ABCA3
plays an important role in the formation of pulmonary surfactant
in type II cells. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
The ATP-binding cassette (ABC) transporter superfamily is
one of the largest gene families, encoding highly conserved
proteins involved in energy-dependent transport of a variety
of substrates across membrane, including ions, amino acids,
peptides, carbohydrates, and lipids [1]. Among the several
subclasses of ABC transporters, the ABCA subclass [2] has
received considerable attention because mutation of the
ABCA1/ABC1 or the ABCA4/ABCR gene causes Tangier dis-
ease accompanying high density lipoprotein de¢ciency [3,4] or
Stargardt’s macular dystrophy [5] in human, respectively. In
addition to ABCA1 and ABCA4, ¢ve other members,
ABCA2/ABC2 [6], ABCA3/ABC3 (ABC-C) [7,8], ABCA6
[9], ABCA7 [10], and ABCA8 [9], have been shown to belong
to the ABCA subclass to date. ABCA1 and ABCA4 are pro-
posed to be transmembrane transporters for intracellular cho-
lesterol/phospholipids [3,4,11] and protonated N-retinylidene-
phosphatidylethanolamine [12], respectively. ABCA2,
ABCA3, and ABCA7 mRNA levels have been reported to
be upregulated by the sustained cholesterol in£ux mediated
by modi¢ed low density lipoprotein [13,14], suggesting that
ABCA transporters including ABCA3 are involved in trans-
membrane transport of endogenous lipids [4].
ABCA3, which was originally cloned from a cDNA library
constructed from human medullary thyroid carcinoma cell
line [7] or from human genomic DNA by exon-trapping [8],
is expressed predominantly in the human lung [7,8]. However,
the distribution and function of ABCA3 in the lung remain
unknown, and it has not been cloned from lung tissues.
In the present study, we cloned ABCA3 from human lung
and generated a speci¢c antibody against it, and found that
the 150-kDa ABCA3 protein is expressed predominantly at
the limiting membrane of the lamellar bodies in the type II
cells in human lung alveolar structures. The data suggest that
ABCA3 may play an important role in the formation of pul-
monary surfactant, which is composed mainly of phospholip-
ids and speci¢c surfactant proteins [15].
2. Materials and methods
2.1. Construction of human ABCA3 expression vector
7.2U105 plaques of a human lung cDNA library (Stratagene) were
screened under the standard hybridization conditions [16] using DNA
fragments of mouse EST clones AW900257 and AA638829, which
contain the regions corresponding to the 5P-untranslated region to
nucleotide +1020 (relative to the putative translation start site) and
nucleotide +4820 to the 3P-untranslated region of human ABCA3
cDNA, respectively, as probes. Three of the positive 71 clones, VhAB-
CA3-5-1, VhABCA3-5-4, and VhABCA3-3-17, were subcloned and
sequenced. In addition, to obtain the DNA fragment covering the
middle region of human ABCA3, the DNA fragment from +2475
to +4313 was ampli¢ed by polymerase chain reaction (PCR) using
human lung cDNA (Clontech), subcloned, and sequenced. Using
these DNA fragments, the expression vector (pCMVhABCA3) carry-
ing the full-length cDNA of human ABCA3 was constructed.
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2.2. Tissue preparation, cell culture, and transfection
Human lung tissue was obtained from adult patients undergoing
surgical removal for various reasons. Culture and transfection of
HEK 293 cells were carried out as previously described [17]. 2 Wg of
pCMVhABCA3 or pCMV vector was transfected into cells with Lipo-
fectamine and Opti-MEM I (Life Technologies, Inc.), according to the
manufacturer’s instructions.
2.3. Crude membrane preparation
Crude membrane of transfected HEK 293 cells or human lung
tissue was prepared as previously described [6,17]. Brie£y, for trans-
fected HEK 293 cells, 3 days after transfection with pCMVhABCA3
or pCMV vector alone, the cells were washed, suspended in bu¡er A
consisting of 50 mM Tris (pH 7.5) and 1 mM EDTA containing
protease inhibitor cocktail (10 Wl/ml) (Sigma), homogenized, and
then ultracentrifuged at 100 000Ug at 4‡C for 1 h. The pellets were
resuspended in 500 Wl of bu¡er A and stored at 380‡C until immu-
noblot analysis. For lung tissue, the tissue in bu¡er A (10% volume)
containing protease inhibitor cocktail (10 Wl/ml) was homogenized in
a Te£on pestle-glass homogenizer on ice and centrifuged at 800Ug for
7 min at 4‡C. The supernatant was then subjected to ultracentrifuga-
tion, and the pellet was resuspended and stored as described above.
Protein concentrations were determined using the BCA assay (Pierce,
Rockford, IL, USA).
2.4. Primary antibodies
The speci¢c antibody for ABCA3 was raised in a rabbit against the
synthetic peptide corresponding to 13 C-terminal amino acid residues
(FAHLQPPTAEEGR) of human ABCA3, which di¡ers construc-
tively from other ABCA transporters and any other protein from
the sequence databases. The antibody was puri¢ed using a⁄nity chro-
matography (HiTrap Protein G, Amersham Pharmacia Biotech). For
double-immuno£uorescence staining, a mouse monoclonal IgG anti-
body against human surfactant protein A (SP-A, PE-10, Dako, Japan)
or a mouse monoclonal antibody against Hsp-60 of mitochondria
(MBL, Nagoya, Japan) was used.
2.5. Immunoblot analysis
The crude membrane proteins prepared from transfected HEK 293
cells (10 Wg) and human lung tissue (20 Wg) were boiled in SDS
reducing sample bu¡er, electrophoresed on 7% SDS^polyacrylamide
gel, and transferred to a nitrocellulose membrane (Hybond ECL,
Amersham Pharmacia Biotech) as previously described [6]. After
blocking and washing [6], the membrane was incubated with 1:1000
diluted anti-ABCA3 antibody for 2 h at room temperature. After
washing, the membrane was incubated with 1:5000 diluted horserad-
ish peroxidase-conjugated anti-rabbit IgG (Amersham Pharmacia Bio-
tech) for 1 h, followed by washing [6]. Proteins were detected using an
enhanced chemiluminescence system (ECL, Amersham Pharmacia Bi-
otech).
2.6. Immunohistochemistry
Portions of human lung tissue were ¢xed by immersion with 4%
paraformaldehyde containing 0.1% glutaraldehyde in 0.1 M phos-
phate bu¡er (PB, pH 7.2) for 1 day at 4‡C. After washing with 0.1
M PB, the ¢xed tissues were trimmed to smaller pieces, incubated for
two nights in 30% sucrose in 0.1 M phosphate-bu¡ered saline (PBS),
and cut into 8 Wm thick sections on a cryostat (MICROM HM 500;
MICROM, Heidelberg, Germany). The sections were rinsed with
PBS, preincubated with 10% normal goat serum in PBS, and then
incubated with 1:10 000 diluted anti-ABCA3 antibody. After incuba-
tion, the sections were immunostained by the avidin^biotin complex
methods (Vector, Burlingame, CA, USA), and were subsequently in-
cubated with a 3,3P-diaminobenzidine-4HCl (DAB) kit (Vector) for
about 5 min. The sections were mounted and observed with an Olym-
pus AX-70 microscope (Olympus, Tokyo, Japan).
Fig. 1. Immunoblot analysis of ABC3 protein. Membrane proteins
prepared from human lung tissue (20 Wg) (lane 1) and HEK 293
cells transfected with pCMVhABCA3 (10 Wg) (lane 2) and empty
vector (pCMV; mock) (10 Wg) (lane 3) were electrophoresed on a
7% SDS^polyacrylamide gel. For immunoblot analysis, an anti-
ABCA3 rabbit antibody and a horseradish peroxidase-conjugated
anti-rabbit IgG were used as the primary and secondary antibodies,
respectively. Proteins were detected using an enhanced chemilumi-
nescence system. Molecular weights of markers are indicated on the
left, and the detected V180-kDa, 150-kDa, and 130-kDa bands are
indicated by arrows.
Fig. 2. Immunohistochemical labeling of ABCA3 by DAB reaction
of human lung tissue cryosections. A: Immunoreactive round or cu-
boid cells (arrow) are scattered throughout the alveoli. B: A repre-
sentative immunoreactive cell ; vesicle-like structures are strongly
stained on the surface (arrowhead). Scale bar, 10 Wm.
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2.7. Immunoelectron microscopy
Portions of human lung tissue were incubated for more than 3 days
in cold 1.84 M sucrose in 0.1 M PB containing 20% polyvinyl pyrro-
lidone. After being cut into very small pieces, they were rapidly frozen
in liquid nitrogen at 3196‡C. Frozen ultrathin sections (100 nm) were
cut with a Leica Ultracut S/FCS (Vienna, Austria). The sections were
picked up on a formvar-carbon-coated nickel grid, incubated with 2%
gelatin in PBS containing 10 mM glycine, and allowed to react over-
night with 1:1000 diluted anti-ABCA3 antibody. The tissues were
washed ¢ve times with glycine-PBS containing 0.5% gelatin and
then for 2 h with 10 nm colloidal gold-labeled goat anti-rabbit IgG
antibody (2 Wg/ml) (British Biocell International, UK). After being
washed again, the sections were post-¢xed in 0.1% glutaraldehyde,
stained with 2% uranyl acetate, embedded in polyvinyl alcohol, and
observed with a Jeol JEM-1200 EX II electron microscope (Jeol,
Tokyo, Japan).
2.8. Confocal laser scanning microscopy
Tissues with brief ¢xation in 4% bu¡ered paraformaldehyde were
embedded in OCT compound, snap frozen in acetone^dry ice, and
stored at 380‡C until sectioning. A double indirect immuno£uores-
cence method was applied to sections of 4 Wm or 30 Wm thickness. The
sections were incubated overnight at 4‡C with a combination of 1:500
diluted anti-ABCA3 antibody and 1:100 diluted anti-SP-A antibody
or 1:200 diluted anti-Hsp-60 antibody as primary antibodies. After
washing several times, the sections were incubated with a mixture of
two secondary antibodies consisting of 1:100 diluted each of £uores-
cein isothiocyanate-labeled goat anti-rabbit IgG and Texas red-labeled
horse anti-mouse IgG (Vector Laboratories, Burlingame, CA, USA),
for 40 min at room temperature in the dark. Nuclear counterstaining
was done for 15 min at room temperature with 0.01% TOTO-3 iodide
(Molecular Probes, Eugene, OR, USA). The sections were examined
with a confocal laser scanning microscope (TC-SP; Leica, Heidelberg,
Germany) equipped with argon and argon^krypton laser sources.
3. Results and discussion
Screening a human lung cDNA library and amplifying hu-
man lung cDNA using PCR, we cloned a full-length human
ABCA3 cDNA encoding a 1704 amino acid protein. The ami-
no acid sequence predicted from the composite sequence
(from nucleotide 342 to +5196 relative to the putative trans-
lation start site) is identical to that cloned from the human
medullary thyroid carcinoma cell line [7], while the 196th ami-
no acid residue (proline) is di¡erent from that (leucine) of the
ABCA3 protein cloned from genomic DNA by exon-trapping
[8]. There are also two polymorphic sites without amino acid
substitution at nucleotide +798 (T) and +1176 (T) that are
di¡erent from the two sequences previously reported (C at
both sites) [7,8].
ABCA3 protein then was analyzed by immunoblotting us-
ing the antibody generated against human ABCA3. A single
band at 150 kDa was detected from the crude membrane
fraction of human lung tissue (Fig. 1, lane 1). To ascertain
speci¢city of the antibody, crude membrane fractions of trans-
fected HEK 293 cells were examined. Four bands, two close
bands at about 180 kDa and one at 150 kDa and 130 kDa,
were detected in HEK 293 cells transfected with ABCA3 ex-
pression vector (pCMVhABCA3) (Fig. 1, lane 2), but no band
was detected in cells transfected with vector alone (pCMV)
(Fig. 1, lane 3). These results indicate that ABCA3 is a 150-
kDa protein in the lung. The reason why several bands are
detected in HEK 293 cells and the molecular size detected in
the lung is smaller than that predicted from the deduced ami-
Fig. 3. Immunogold labeling of ABCA3 in cryo-ultrathin sections of human alveolar type II cells. A: Many gold labelings appear on the limit-
ing membrane of lamellar bodies. A few gold particles are localized in a patch on the plasma membrane (arrow). Scale bar, 500 nm. B: Multi-
vesicular bodies near the lamellar bodies also are labeled on the limiting membrane. Endoplasmic reticulum is not labeled. Scale bar, 250 nm.
C: Golgi cisternal edge (indicated by arrows) is labeled only sparsely. Mitochondria and nucleus are not signi¢cantly labeled. Scale bar, 250
nm. L: lamellar body, MV: multivesicular body, ER: endoplasmic reticulum, G: Golgi apparatus, M: mitochondria, N: nucleus.
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no acid sequence (191 kDa) is unknown, but may be post-
translational modi¢cation.
We then examined the expression of ABCA3 in human lung
by DAB reaction. ABCA3 immunoreactivity appears to be
very intense in the comparatively large, round or cuboid cells
scattered in the alveolar epithelium (Fig. 2A). Where vesicle-
like structures appear in the cells, their surfaces are stained
especially strongly (Fig. 2B).
To further examine the intracellular localization of ABCA3,
an immunoelectron microscopic study with colloidal gold la-
bel on ultrathin cryosections of human lung was performed.
Immunogold particles were observed mainly in cells with ap-
ical microvilli on the plasma membrane (Fig. 3A), a feature of
type II cells. Major labelings are associated with lamellar
bodies speci¢c to type II cells, and most are localized exclu-
sively on the limiting membranes and not inside the lamellar
bodies (Fig. 3A^C). Immunolabelings also appear on the sur-
faces of multivesicular bodies (Fig. 3B), and there are sparse
patches of gold particles on the cell membrane (Fig. 3A).
Golgi cisternal edges and Golgi vesicles (Fig. 3C) also are
labeled sparsely. The endoplasmic reticulum, mitochondria,
and nucleus all are devoid of gold particles (Fig. 3B,C).
To con¢rm that ABCA3 is expressed in type II cells, a
double-immuno£uorescence staining experiment was per-
formed using both the anti-ABCA3 antibody and an antibody
against SP-A, which is known to be expressed in both alveolar
type II cells and bronchiolar Clara cells in the lung [15]. As
shown in Fig. 4, cells double-immunolabeled for ABCA3 and
SP-A are scattered throughout the alveolus, clearly showing
that ABCA3 is expressed in alveolar type II cells. Closer ex-
amination reveals immunoreactivity for ABCA3 and SP-A
mainly in the cytosol, but with di¡erent distribution patterns.
ABCA3 consistently stained a ring-like structure (Fig. 4B),
probably re£ecting the rim of the lamellar body, which often
lacked reactivity to SP-A. This is consistent with a previous
report that SP-A immunoreactivity is present abundantly on
rough endoplasmic reticulum and the Golgi apparatus and
associated small vesicles but at low levels on lamellar and
multivesicular bodies in type II cells [18]. We further con-
¢rmed that Hsp-60 is localized only in mitochondria, which
are clearly distinct from the ABCA3-labeled ring-like struc-
tures in type II cells (data not shown). The expression of
ABCA3 in Clara cells in the airway was not examined in
this study.
Pulmonary surfactant, composed mainly of phospholipids
and speci¢c surfactant proteins, reduces the surface tension at
the alveolar air/liquid interface, and thereby prevents the
lungs from collapsing [15]. The main phospholipid compo-
nent, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, is unique
in that two acyl chains in the molecule are both saturated.
Pulmonary surfactant is represented by several di¡erent struc-
tural entities including the lamellar bodies, tubular myelin,
and the monolayers of lipid and proteins. Lamellar bodies
are dense multilayer structures formed in type II cells and
secreted into alveolar space by exocytosis. The mechanism
by which phospholipids are packaged into the lamellar body
Fig. 4. Immunohistochemical labeling of ABCA3 and SP-A of human lung tissue cryosections. A^C: Low power view of alveolar walls of hu-
man lung. Type II cells, in which both ABCA3 (A) and SP-A (B) are present, are located on the alveolar wall, as indicated by arrows. Merged
picture is shown in C. The many cells not labeled with ABCA3 or SP-A (blue) are nuclei. The structures of yellow color in C which correspond
to elastic ¢bers of alveolar walls or perivascular elastic ¢bers are also observed. Scale bar, 20 Wm. D^F: High power view of a representative
type II cell. The surrounding structure in green £uorescence (ABC3) (D) does not completely overlap the red £uorescence mass (SP-A) (E) in
the merged picture (F). Scale bar, 10 Wm. Green £uorescence shows localization of ABC3 protein, red £uorescence SP-A, and blue £uorescence
nuclei.
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is unknown, but ABCA transporters have been shown re-
cently to be involved in transmembrane transport of endoge-
nous lipids [3,4,11,12], so ABCA3 might well function as a
transmembrane transporter of the phospholipid components
of pulmonary surfactant.
Shuman’s group has generated monoclonal antibodies
against the lamellar body membrane fraction of type II cells
prepared from rat lung. One of them (Mab 3C9) recognizes
speci¢cally a 180-kDa integral membrane protein occurring
primarily on the lamellar body [19]. In addition, they reported
very recently that ABCA3 mRNA is abundant in type II cells
and that its expression is induced highly during fetal lung
di¡erentiation [20]. Whether or not the Mab 3C9 antibody
recognizes the ABCA3 protein is an intriguing question;
although the molecular size of the ABCA3 protein detected
by our antibody is di¡erent from that detected by the Mab
3C9 antibody, this might re£ect species di¡erence.
We have shown recently that ABCA2 is expressed exclu-
sively in the oligodendrocytes in brain [17]. Oligodendrocytes
produce the lamellar structure myelin, which is composed of
phospholipids and speci¢c myelin proteins. ABCA2 immuno-
reactivity is detected mostly around lysosomes [17]. Interest-
ingly, the lamellar body of type II cells shares membrane
proteins with lysosomes [21,22]. These results suggest that
the structurally related ABCA2 and ABCA3 both are associ-
ated with the function of lysosomes. Further studies to clarify
the functional roles of ABCA3 are needed.
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